Related references
Note: Only part of the references are listed.Soluble TREM2 in CSF and its association with other biomarkers and cognition in autosomal-dominant Alzheimer's disease: a longitudinal observational study
Estrella Morenas-Rodriguez et al.
LANCET NEUROLOGY (2022)
Elevating microglia TREM2 reduces amyloid seeding and suppresses disease-associated microglia
Na Zhao et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2022)
Identification of the minimal active soluble TREM2 sequence for modulating microglial phenotypes and amyloid pathology
Xuan Sheng et al.
JOURNAL OF NEUROINFLAMMATION (2021)
TREM2/PLCγ2 signalling in immune cells: function, structural insight, and potential therapeutic modulation
Lorenza Magno et al.
MOLECULAR NEURODEGENERATION (2021)
Higher CSF sTREM2 and microglia activation are associated with slower rates of beta‐amyloid accumulation
Michael Ewers et al.
EMBO Molecular Medicine (2020)
The Physiology, Pathology, and Potential Therapeutic Applications of the TREM2 Signaling Pathway
Aleksandra Deczkowska et al.
CELL (2020)
The endogenous neuronal complement inhibitor SRPX2 protects against complement-mediated synapse elimination during development
Qifei Cong et al.
NATURE NEUROSCIENCE (2020)
Complement in neurological disorders and emerging complement-targeted therapeutics
Marinos C. Dalakas et al.
NATURE REVIEWS NEUROLOGY (2020)
Trem2 Y38C mutation and loss of Trem2 impairs neuronal synapses in adult mice
Vaishnavi S. Jadhav et al.
MOLECULAR NEURODEGENERATION (2020)
ApoE attenuates unresolvable inflammation by complex formation with activated C1q
Changjun Yin et al.
NATURE MEDICINE (2019)
Soluble TREM2 ameliorates pathological phenotypes by modulating microglial functions in an Alzheimer's disease model
Li Zhong et al.
NATURE COMMUNICATIONS (2019)
Galectin-3, a novel endogenous TREM2 ligand, detrimentally regulates inflammatory response in Alzheimer's disease
Antonio Boza-Serrano et al.
ACTA NEUROPATHOLOGICA (2019)
Increased soluble TREM2 in cerebrospinal fluid is associated with reduced cognitive and clinical decline in Alzheimer's disease
Michael Ewers et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
The MS4A gene cluster is a key modulator of soluble TREM2 and Alzheimer's disease risk
Yuetiva Deming et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Complement C3 Is Activated in Human AD Brain and Is Required for Neurodegeneration in Mouse Models of Amyloidosis and Tauopathy
Tiffany Wu et al.
CELL REPORTS (2019)
The Emerging Roles and Therapeutic Potential of Soluble TREM2 in Alzheimer's Disease
Li Zhong et al.
FRONTIERS IN AGING NEUROSCIENCE (2019)
The Microglial Innate Immune Receptor TREM2 Is Required for Synapse Elimination and Normal Brain Connectivity
Fabia Filipello et al.
IMMUNITY (2018)
Menin Deficiency Leads to Depressive-like Behaviors in Mice by Modulating Astrocyte-Mediated Neuroinflammation
Lige Leng et al.
NEURON (2018)
Differential effects of partial and complete loss of TREM2 on microglial injury response and tauopathy
Faten A. Sayed et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Changes in the Synaptic Proteome in Tauopathy and Rescue of Tau-Induced Synapse Loss by C1q Antibodies
Borislav Dejanovic et al.
NEURON (2018)
Complement C3aR Inactivation Attenuates Tau Pathology and Reverses an Immune Network Deregulated in Tauopathy Models and Alzheimer's Disease
Alexandra Litvinchuk et al.
NEURON (2018)
Soluble TREM2 induces inflammatory responses and enhances microglial survival
Li Zhong et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
TREM2-Ligand Interactions in Health and Disease
Daniel L. Kober et al.
JOURNAL OF MOLECULAR BIOLOGY (2017)
Cell-specific deletion of C1qa identifies microglia as the dominant source of C1q in mouse brain
Maria I. Fonseca et al.
JOURNAL OF NEUROINFLAMMATION (2017)
Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss
Michael X. Hernandez et al.
MOLECULAR NEURODEGENERATION (2017)
TREM2 deficiency exacerbates tau pathology through dysregulated kinase signaling in a mouse model of tauopathy
Shane M. Bemiller et al.
MOLECULAR NEURODEGENERATION (2017)
ADAM17 is the main sheddase for the generation of human triggering receptor expressed in myeloid cells (hTREM2) ectodomain and cleaves TREM2 after Histidine 157
Dominik Feuerbach et al.
NEUROSCIENCE LETTERS (2017)
TREM2 deficiency attenuates neuroinflammation and protects against neurodegeneration in a mouse model of tauopathy
Cheryl E. G. Leyns et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Complement C3 deficiency protects against neurodegeneration in aged plaque-rich APP/PS1 mice
Qiaoqiao Shi et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
TREM2 shedding by cleavage at the H157-S158 bond is accelerated for the Alzheimer's disease-associated H157Y variant
Peter Thornton et al.
EMBO MOLECULAR MEDICINE (2017)
An Alzheimer-associated TREM2 variant occurs at the ADAM cleavage site and affects shedding and phagocytic function
Kai Schlepckow et al.
EMBO MOLECULAR MEDICINE (2017)
Disease Progression-Dependent Effects of TREM2 Deficiency in a Mouse Model of Alzheimer's Disease
Taylor R. Jay et al.
JOURNAL OF NEUROSCIENCE (2016)
TREM2 Binds to Apolipoproteins, Including APOE and CLU/APOJ, and Thereby Facilitates Uptake of Amyloid-Beta by Microglia
Felix L. Yeh et al.
NEURON (2016)
Complement and microglia mediate early synapse loss in Alzheimer mouse models
Soyon Hong et al.
SCIENCE (2016)
Neurodegenerative disease mutations in TREM2 reveal a functional surface and distinct loss-of-function mechanisms
Daniel L. Kober et al.
ELIFE (2016)
TREM2 Lipid Sensing Sustains the Microglial Response in an Alzheimer's Disease Model
Yaming Wang et al.
CELL (2015)
Apolipoprotein E Is a Ligand for Triggering Receptor Expressed on Myeloid Cells 2 (TREM2)
Yuka Atagi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
The Triggering Receptor Expressed on Myeloid Cells 2 Binds Apolipoprotein E
Charles C. Bailey et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Sequential Proteolytic Processing of the Triggering Receptor Expressed on Myeloid Cells-2 (TREM2) Protein by Ectodomain Shedding and γ-Secretase-dependent Intramembranous Cleavage
Patrick Wunderlich et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
TREM2 Variants in Alzheimer's Disease
Rita Guerreiro et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Complement: a key system for immune surveillance and homeostasis
Daniel Ricklin et al.
NATURE IMMUNOLOGY (2010)
Treatment with a C5aR Antagonist Decreases Pathology and Enhances Behavioral Performance in Murine Models of Alzheimer's Disease
Maria I. Fonseca et al.
JOURNAL OF IMMUNOLOGY (2009)
A role for TREM2 ligands in the phagocytosis of apoptotic neuronal cells by microglia
Christine L. Hsieh et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Complement regulators and inhibitory proteins
Peter F. Zipfel et al.
NATURE REVIEWS IMMUNOLOGY (2009)
The classical complement cascade mediates CNS synapse elimination
Beth Stevens et al.
CELL (2007)
Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model
Yasumasa Yoshiyama et al.
NEURON (2007)
Mutations in two genes encoding different subunits of a receptor signaling complex result in an identical disease phenotype
J Paloneva et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2002)
Protein detection using proximity-dependent DNA ligation assays
S Fredriksson et al.
NATURE BIOTECHNOLOGY (2002)
β-amyloid fibrils activate the C1 complex of complement under physiological conditions:: Evidence for a binding site for Aβ on the C1q globular regions
P Tacnet-Delorme et al.
JOURNAL OF IMMUNOLOGY (2001)
Complement activation by neurofibrillary tangles in Alzheimer's disease
Y Shen et al.
NEUROSCIENCE LETTERS (2001)
Share Paper
